Onsior

RSS

robenacoxib

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of Onsior and why it is authorised in the EU

Onsior is an anti-inflammatory veterinary medicine for use in cats and dogs to treat pain and inflammation.

In cats, Onsior tablets are used to treat pain and inflammation associated with acute (short term) and chronic (long term) musculoskeletal disorders (problems with the muscles and bones) and to reduce moderate pain and inflammation associated with orthopaedic (bone) surgery. The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery, such as neutering.

In dogs, Onsior tablets are used to treat pain and inflammation associated with chronic osteoarthritis (a long-term disease causing pain and inflammation in the joints). The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery.

Onsior contains the active substance robenacoxib.

This EPAR was last updated on 13/08/2018

Authorisation details

Product details
Name
Onsior
Agency product number
EMEA/V/C/000127
Active substance
robenacoxib
International non-proprietary name (INN) or common name
robenacoxib
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AH91
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
11
Date of issue of marketing authorisation valid throughout the European Union
15/12/2008
Contact address

Heinz-Lohmann-Str 4
27472 Cuxhaven
Germany

Product information

02/08/2018 Onsior - EMEA/V/C/000127 - T/0019

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Anti inflammatory and antirheumatic products

Therapeutic indication

Cats:

Relief of pain and inflammation associated with acute and chronic musculo-skeletal disorders.

For the reduction of moderate pain and inflammation associated with orthopaedic surgery.

Dogs:

Treatment of pain and inflammation associated with chronic osteoarthritis.

Cats and dogs:

Treatment of pain and inflammation associated with orthopaedic or soft tissue surgery in dogs and with soft tissue surgery.

Assessment history

How useful was this page?

Add your rating